Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedSep 23, 2015Morphine 30 mg/ml + Clonidine 250 mcg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1595-2015Class IITerminatedSep 23, 2015Morphine 30 mg/ml + Bupivacaine 5 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1594-2015Class IITerminatedSep 23, 2015Morphine 30 mg/ml + Baclofen 10 mcg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1593-2015Class IITerminatedSep 23, 2015Morphine 25 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1592-2015Class IITerminatedSep 23, 2015Morphine 25 mg/ml + Baclofen 100 mcg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1591-2015Class IITerminatedSep 23, 2015Morphine 20 mg/ml + Clonidine 500 mcg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1590-2015Class IITerminatedSep 23, 2015Morphine 20 mg/ml + Clonidine 400 mcg/ml Solution Sterile-Preservative FreeLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1589-2015Class IITerminatedSep 23, 2015Morphine 20 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1588-2015Class IITerminatedSep 23, 2015Morphine 15 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1587-2015Class IITerminatedSep 23, 2015Morphine 12.5 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1586-2015Class IITerminatedSep 23, 2015Morphine 10 mg/ml SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1585-2015Class IITerminatedSep 23, 2015Mitomycin 40 mg/50 ml Sodium Chloride 0.9% InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1584-2015Class IITerminatedSep 23, 2015Mitomycin 40 mg/40 ml Sodium Chloride 0.9% InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1583-2015Class IITerminatedSep 23, 2015Mitomycin 0.03% Ophthalmic SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1582-2015Class IITerminatedSep 23, 2015Mitomycin 0.02% Ophthalmic SolutionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1581-2015Class IITerminatedSep 23, 2015MIC-PLUS Carnitine InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1580-2015Class IITerminatedSep 23, 2015MIC-B12+B6 InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1579-2015Class IITerminatedSep 23, 2015MIC-B COMPLEX InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1578-2015Class IITerminatedSep 23, 2015MIC+Methylcobalamin 4000 mcg/ml InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1577-2015Class IITerminatedSep 23, 2015Methylcobalamin 7.5 mg/ml + Methionine 25 mg/ml + Inositol 50 mg/ml + Choline 50 mg/ml InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1576-2015Class IITerminatedSep 23, 2015Methylcobalamin 1Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1575-2015Class IITerminatedSep 23, 2015Methylcobalamin 10 mg/ml + 5 Methyl Tetrahydrofolate 4 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1574-2015Class IITerminatedSep 23, 2015Methylcobalamin 25Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1573-2015Class IITerminatedSep 23, 2015Methylcobalamin 5Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1572-2015Class IITerminatedSep 23, 2015Methylcobalamin 4Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1571-2015Class IITerminatedSep 23, 2015Methylcobalamin 10Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1570-2015Class IITerminatedSep 23, 2015Methylcobalamin 1Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1569-2015Class IITerminatedSep 23, 2015Methionine 25 mg/ml + Inositol 50 mg/ml + Choline 50 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1568-2015Class IITerminatedSep 23, 2015Methionine 25 mg/ml + Inositol 50 mg/ml + Choline 25 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1567-2015Class IITerminatedSep 23, 2015Mannitol 5% InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1566-2015Class IITerminatedSep 23, 2015Magnesium Sulfate 500 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1565-2015Class IITerminatedSep 23, 2015Magnesium Chloride 200 mg/mlLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1564-2015Class IITerminatedSep 23, 2015Lidocaine 2% with Epinephrine 1:100Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1563-2015Class IITerminatedSep 23, 2015Lidocaine 1% InjectionLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1562-2015Class IITerminatedSep 23, 2015L-Arginine 100 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1561-2015Class IITerminatedSep 23, 2015Hydroxyprogesterone CaproateLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1560-2015Class IITerminatedSep 23, 2015Hydroxocobalamin 10 mg/ml Folic Acid 4 mg/ml InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1559-2015Class IITerminatedSep 23, 2015Hydroxocobalamin 5Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1558-2015Class IITerminatedSep 23, 2015Hydroxocobalamin 10Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1557-2015Class IITerminatedSep 23, 2015Hydroxocobalamin 1Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1556-2015

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.